Goodman Noah
Insider CIK 2060075 · KYMR Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 3,389 | $114.29 | $387.3K | 47,179 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-06-25 | 2026-06-25 | 5,000 | — | $0 | 90,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-06-25 | 2026-06-25 | 5,000 | $21.05 | $105.3K | 55,195 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 2,500 | $109.00 | $272.5K | 52,695 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-25 | 2026-06-25 | 2,500 | $119.00 | $297.5K | 50,195 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-06-22 | 2026-06-22 | 2,500 | — | $0 | 95,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-22 | 2026-06-22 | 2,500 | $99.00 | $247.5K | 50,195 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-06-22 | 2026-06-22 | 2,500 | $21.05 | $52.6K | 52,695 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-16 | 1,347 | $90.00 | $121.2K | 50,195 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-10 | 2026-04-10 | 2,000 | $87.35 | $174.7K | 51,542 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-09 | 2026-04-10 | 2,500 | — | $0 | 97,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-09 | 2026-04-10 | 2,500 | $89.00 | $222.5K | 53,542 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-09 | 2026-04-10 | 2,670 | $87.11 | $232.6K | 56,042 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-09 | 2026-04-10 | 2,500 | $21.05 | $52.6K | 61,806 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-09 | 2026-04-10 | 3,094 | $86.62 | $268.0K | 58,712 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-03-02 | 2026-03-04 | 18,450 | — | $0 | 18,450 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2026-03-02 | 2026-03-04 | 9,225 | — | $0 | 59,306 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-04-08 | 2025-04-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2025-04-08 | 2025-04-09 | 50,000 | — | $0 | 50,081 | SEC↗ |